Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of “Hold” from Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have been assigned a consensus recommendation of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $180.40.

MASI has been the subject of several research analyst reports. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Stifel Nicolaus set a $180.00 target price on Masimo in a research note on Tuesday, February 17th. Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday, March 18th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Finally, Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Masimo by 3.7% in the third quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock valued at $709,717,000 after buying an additional 171,876 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Masimo by 1.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after buying an additional 43,915 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in shares of Masimo by 9.6% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,330,158 shares of the medical equipment provider’s stock valued at $303,061,000 after buying an additional 203,395 shares during the period. Naya Capital Management UK Ltd. acquired a new position in shares of Masimo in the fourth quarter valued at approximately $202,984,000. Finally, Westfield Capital Management Co. LP increased its stake in shares of Masimo by 7.2% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after buying an additional 102,799 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Up 0.1%

Shares of NASDAQ MASI opened at $178.81 on Friday. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The company has a market cap of $9.36 billion, a price-to-earnings ratio of -16.96, a PEG ratio of 1.81 and a beta of 1.13. Masimo has a 12 month low of $125.94 and a 12 month high of $179.00. The stock has a 50-day moving average price of $178.12 and a two-hundred day moving average price of $157.09.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.